019736 S31 M1 1571
Document text
BioNTech RNA Pharmaceuticals GmbH 07/10/2020 An der Goldgrube 12 Mainz N/A Germany 55131215-280-5503 COVID-19 Vaccine (BNT162, PF-07302048) 019736 Prophylactic immunization against COVID-19 in adults 18 years of age 0 0 3 0 3 FDA-CBER-2021 5683-1072441 Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Elisa Harkins, Global Regulatory Lead, Pfizer Global Regulatory Affairs - Vaccines 215-280-5503 (845) 474-3500 500 Arcola Road Collegeville PA United States of America [email protected] 07/09/2020 United States of America Elisa Harkins TullDigitally signed by Elisa Harkins Tull Date: 2020.07.09 16:05:54 -04'00' 3 FDA-CBER-2021-5683-1072442 3 FDA-CBER-2021-5683-1072443